Internal Medicine, Pulmonary Disease · Santa Cruz, CA
NPI
1861465932
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1595 Soquel Dr Ste 230
Santa Cruz, CA, 95065
Phone (831) 226-3225
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
1,346 services
Medicare patients, 2024
406
Average age 75
Drug cost, 2024
$1.4M
2,783 prescriptions
Company payments, 2025
$74.79
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Ellison was code 99213 (office e&m - established), 674 times for 300 patients. In total Michael J Ellison billed 1,346 services in 23 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 674 | 300 | $72.88 | $49K |
| 99214 Office E&M - Established | Office | 371 | 163 | $104.78 | $39K |
| 99205 Office E&M - New | Office | 61 | 61 | $182.28 | $11K |
| G0008 Administration of influenza virus vaccine | Office | 59 | 59 | $34.63 | $2,043 |
| 90653 Vaccine Product | Office | 51 | 51 | $81.82 | $4,173 |
| 94010 Pulmonary Function Testing | Office | 22 | 19 | $24.98 | $550 |
| 99442 Telephone Services | Office | 21 | 19 | $71.53 | $1,502 |
| 99215 Office E&M - Established | Office | 14 | 13 | $162.87 | $2,280 |
By year: 2022 $135K for 1,439 services; 2023 $127K for 1,415 services; 2024 $119K for 1,346 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Ellison prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 307 prescriptions and refills. In total Michael J Ellison wrote 2,783 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 307 | 380 | 57 | $237K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 285 | 356 | 85 | $12K |
| Breo Ellipta Fluticasone/Vilanterol | 245 | 329 | 44 | $125K |
| Montelukast Sodium Generic | 220 | 534 | 56 | $2,848 |
| Azithromycin Generic | 189 | 191 | 89 | $1,234 |
| Prednisone Generic | 174 | 188 | 65 | $1,360 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 97 | 118 | 22 | $11K |
| Incruse Ellipta Umeclidinium Bromide | 92 | 114 | 16 | $36K |
| Arnuity Ellipta Fluticasone Furoate | 61 | 75 | 13 | $18K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 59 | 93 | 12 | $40K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 47 | 77 | 16 | $8,596 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 44 | 64 | 12 | $33K |
| Eliquis Apixaban | 39 | 58 | Under 11 | $33K |
| Fluticasone Propionate Generic | 38 | 76 | 15 | $583 |
| Doxycycline Hyclate Generic | 35 | 35 | 12 | $248 |
Brand drugs: 1,455 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Ellison $74.79 ($74.79 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $41.17.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.